Option chain shows key data for Maze Therapeutics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Maze Therapeutics.

Maze Therapeutics (NASDAQ:MAZE) Stock, Option Chain

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Insmed’s Stellar Performance Draws Attention

News

Initiation

Markets

Analyst Ratings

Trading Ideas

Morgan Stanley Market Vectors Rupee/USD ETN

INSM

KRUS

MAZE

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Tesla Inc.

Pre-Market Outlook

Movers

DOGZ

OPCH

ORIS

PLRX

REPL

SMTC

TSLA

Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session

Wall Street

CENX

FENC

MBOT

MGOL

MYNA

PNBK

PSIG

SATL

SLDB

STBX

YOSH

Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Maze Therapeutics Inc

Financing

Press Releases

Maze Therapeutics Announces Pricing of Upsized Initial Public Offering

Health Care

Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease

BGM Group

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

GH Research

Harrow

Maze Therapeutics

MBX Biosciences

Nuvation Bio

Omeros

Phibro Animal Health Corporation - Class A Common Stock

Phibro Animal Health

Pacira BioSciences

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Terns Pharma

Tilray Brands

Trevi Therapeutics

Xeris Biopharma Holdings, Inc. - Common Stock

Xeris Biopharma Holdings

Zevra Therapeutics

Guggenheim

Leerink Partners

JP Morgan

Comments

Maze Therapeutics

Maze Therapeutics (MAZE) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga